Mayo Clinic Laboratories

Short answer: it depends on which biomarkers, whether values are normal or changing, and whether you have a condition or started a medicine. Below are practical, commonly used retesting intervals and when to test sooner — plus a few lab services you can use. Typical retesting schedules (for adults) Baseline/healthy adults (preventive care) Basic metabolic panel (BMP/CMP), complete blood count (CBC), lipid panel: once a year. HbA1c (if no diabetes, but risk factors): every 6–12 months. Thyroid (TSH): once a year if symptoms or risk factors; less often if asymptomatic and previously normal. Vitamin D: every 6–12 months if supplementing or previously low. If you have a diagnosis or abnormal result Diabetes (A1c): every 3 months until control/stable, then every 3–6 months once stable. Lipids on statin: 4–12 weeks after starting or changing dose, then every 6–12 months. Hypertension with ACEi/ARB or diuretics: serum creatinine and potassium 1–2 weeks after start/change, then periodically (every 3–12 months). Thyroid medication change: check TSH ~6–8 weeks after change, then every 3–12 months when stable. Vitamin D deficiency being actively treated: recheck in ~8–12 weeks after starting supplementation. Ferritin/iron therapy: recheck ferritin after ~8–12 weeks (iron stores take time to recover). Inflammation markers (hs-CRP) or liver enzymes: frequency depends on underlying cause; often every 3 months while evaluating or treating, then less often when stable. Testosterone replacement: check levels and hematocrit at baseline, after 3 months, then every 6–12 months. Acute changes or concerning symptoms Retest sooner (days–weeks) if symptoms worsen, new medication side effects occur, or you have an abnormal lab that could indicate a rapidly changing problem. Other practical notes When starting a new drug, check labs at the intervals recommended for that specific medication (some require early monitoring). If you change lifestyle (major weight loss, new exercise program, big diet change), rechecking some markers (lipids, A1c, vitamin D) after 3–6 months can show impact. For older adults or those with multiple chronic diseases, more frequent monitoring is common. For cancer screening tests (PSA, etc.) follow age- and risk-based guidelines and discuss with your clinician. Where to get tests (brands/services) Quest Diagnostics or Labcorp — large national lab networks; accepted by most doctors/insurers and reliable for full clinical panels. Mayo Clinic Laboratories — high-quality reference testing; often used when specialized testing is needed. Everlywell or LetsGetChecked — at-home or direct-to-consumer kits for A1c, lipids, thyroid, vitamin D, etc.; convenient if you don’t need prescription lab orders (verify accuracy and compare with clinical labs if you have medical conditions). Dexcom or Abbott FreeStyle Libre — continuous glucose monitoring devices for people with diabetes who need real-time glucose trends (not for routine blood tests). Your primary care provider or specialist — best for coordinating testing, interpreting results, and making treatment decisions. If you’d like, tell me: your age, medical conditions, and any meds you’re on — I can propose a specific retesting schedule tailored to you.

Mentioned in position 3 of 7

Short answer: There isn’t a single “best” general food‑sensitivity kit. The only reliable, evidence‑based tests are specific allergy and disease tests ordered by clinicians (skin‑prick and serum specific‑IgE for true allergy; celiac serology/genetics; breath tests for lactose/SIBO). Broad IgG food panels sold direct‑to‑consumer are not supported by the evidence and are not recommended. What to use depending on your problem Suspected immediate (IgE) food allergy: see a board‑certified allergist for skin‑prick testing and/or serum specific‑IgE testing (ImmunoCAP by Thermo Fisher/Phadia is a widely used, validated lab assay). These tests are accurate for diagnosing true allergic (IgE‑mediated) reactions. Suspected celiac disease: order tissue transglutaminase IgA (tTG‑IgA) plus total IgA (and deamidated gliadin peptide IgG if IgA deficient). These are routine, validated tests available through major labs (Quest Diagnostics, LabCorp, Mayo Clinic Laboratories). If needed, HLA‑DQ2/DQ8 genotyping (Quest/LabCorp) helps rule out celiac. Suspected lactose/fructose malabsorption or SIBO: hydrogen (or methane) breath testing through GI clinics or reputable labs (Genova Diagnostics, major hospital GI labs) is the accepted test. Non‑IgE, non‑celiac food‑related symptoms (e.g., IBS, suspected non‑celiac gluten sensitivity): the best approach is a medically supervised elimination diet with systematic re‑challenge; working with a gastroenterologist and a registered dietitian (RD) is the gold standard. There’s no validated single blood test for “food sensitivity” in these cases. Complex GI or inflammatory conditions (eosinophilic esophagitis, IBD): diagnosis requires endoscopy/biopsy and specialist evaluation, not a home panel. What to avoid (these are commonly marketed but not evidence‑based) IgG or IgG4 food panels sold direct‑to‑consumer or by “food sensitivity” companies (examples: Everlywell Food Sensitivity, Vibrant Wellness food sensitivity, ALCAT, Mediator Release Test/MRT). Major allergy/gastroenterology societies do not support using IgG panels to diagnose food intolerance; they often reflect exposure, not intolerance, and lead to unnecessary diet restrictions. Practical next steps Document your symptoms (timing after eating, severity, reproducible triggers). Bring this to your primary care doctor or an allergist/gastroenterologist. They’ll pick targeted, evidence‑based tests (listed above) rather than a shotgun IgG panel. If you need diet changes, work with a registered dietitian during elimination/re‑challenge to keep nutrition safe. If you want, tell me your main symptoms (hives/anaflaxysis vs. gut symptoms vs. chronic bloating/fatigue) and I’ll recommend the most appropriate test and local/online providers or labs.

Mentioned in position 6 of 11

Short answer: there isn’t a single reliable, clinically validated “food sensitivity” blood test sold direct-to-consumer. Many commercial IgG-based panels (Everlywell, Vibrant, Cyrex, ALCAT, some MRT offers) measure IgG or other markers that indicate exposure, not clinically meaningful intolerance, and are not recommended by allergy societies. The safest, evidence-based approach is to use standard allergy and intolerance testing or a medically supervised elimination/rechallenge. What to use instead (by situation) Suspect true allergy (immediate, hives, breathing, anaphylaxis): see an allergist for skin-prick testing or serum specific IgE testing (ImmunoCAP/Phadia assays). Reputable labs that run these assays include Quest Diagnostics, LabCorp and Mayo Clinic Laboratories. These tests detect IgE-mediated allergy and are clinically validated. Suspect celiac disease (bloating, diarrhea, weight loss, iron deficiency): get celiac serology — tissue transglutaminase IgA (tTG‑IgA) plus total IgA (and deamidated gliadin peptides if needed). Available at Quest, LabCorp, Mayo Clinic Labs. Suspect carbohydrate intolerance (lactose/fructose) or SIBO: breath testing (hydrogen/methane) performed by gastroenterology clinics or diagnostic labs (many GI offices, Genova Diagnostics provide kits). These tests are the accepted method for lactose/fructose intolerance and SIBO diagnosis. Non-IgE, delayed or vague symptoms (IBS-like, fatigue, headaches): the best validated approach is a structured elimination diet with careful reintroduction (gold standard: double-blind, placebo-controlled food challenge when needed). Work with a board-certified allergist or a registered dietitian (RD) experienced in food elimination/rechallenge. Why not IgG panels sold direct-to-consumer? IgG antibodies often reflect prior exposure and tolerance, not harmful reaction. Major allergy/immunology organizations (e.g., AAAAI) advise against using IgG testing for diagnosing food intolerance or guiding elimination diets. These tests can lead to unnecessary, restrictive diets that cause nutritional problems and anxiety. If you want a reputable starting point Make an appointment with a board-certified allergist for history and either skin-prick testing or serum specific IgE (ImmunoCAP via Quest/LabCorp/Mayo). For GI-type symptoms, ask your primary care provider or gastroenterologist about breath testing (lactose/fructose/SIBO) and celiac serology. If you choose an elimination diet, consult a registered dietitian (look for RD who specializes in GI/allergy). If you tell me your main symptoms (hives/anaphylaxis, chronic GI symptoms, headaches, eczema, etc.) I can recommend the single best next test or specialist to see.

Mentioned in position 7 of 8

Short answer: there isn’t a single reliable commercial “food sensitivity” panel that proves a food is causing non‑allergic symptoms. The best approach is to use validated tests for specific conditions (allergy, celiac, carbohydrate malabsorption, SIBO) and/or a professionally supervised elimination/rechallenge. Avoid broad IgG food‑panel kits sold direct‑to‑consumer — they’re not diagnostic. What I recommend (by condition), with specific labs/services and why: Suspected immediate allergy (hives, swelling, throat tightness, anaphylaxis) See an allergist for skin‑prick testing and/or serum specific IgE testing (ImmunoCAP by Thermo Fisher/Phadia is the clinical standard). Why: these tests are validated for true IgE‑mediated allergy and an allergist can do (or arrange) a supervised oral food challenge if needed. Suspected celiac disease Get tissue transglutaminase IgA (tTG‑IgA) + total IgA from a clinical lab (Quest Diagnostics, LabCorp, Mayo Clinic Laboratories). Why: serology for celiac is well validated; labs above are reputable and used by clinicians. Suspected lactose/fructose malabsorption or SIBO (bloating, gas, diarrhea after carbs) Get a hydrogen/methane breath test through a GI clinic or hospital lab (many use QuinTron equipment). Why: breath testing is the accepted functional test for lactose/fructose intolerance and SIBO when done and interpreted properly. Non‑specific, delayed GI/extraintestinal symptoms (brain fog, fatigue, chronic IBS‑type symptoms) The most reliable route is a diagnostic elimination diet with systematic reintroduction supervised by a registered dietitian (find one through the Academy of Nutrition and Dietetics). Why: elimination + double‑blind reintroduction is the practical “gold standard” for food‑trigger identification when no IgE/celiac/malabsorption problem is present. What to avoid Commercial IgG / IgG4 food panels (examples: Everlywell food sensitivity test, Vibrant Wellness Food Inflammation Panel, many direct‑to‑consumer panels) — professional societies (AAAI, British Dietetic Association, others) advise against using IgG tests to diagnose food intolerance because IgG often reflects exposure or tolerance, not pathological sensitivity. Unvalidated specialty tests marketed to “find hidden food sensitivities” (cytotoxic tests, MRT/mediator release tests) — evidence is weak or absent. Next steps If you have immediate allergy symptoms: see an allergist now. If you have chronic GI symptoms: start with your primary care or GI doctor for appropriate labs (tTG, breath tests) and ask for referral to a registered dietitian for a supervised elimination diet. If you want help finding clinicians: use AAAAI’s allergist finder, Academy of Nutrition and Dietetics’ RD locator, or major lab network locations (Quest/LabCorp/Mayo) for validated blood tests and breath testing referrals. If you tell me your main symptoms (immediate reactions vs chronic GI vs rashes/brain‑fog), I can recommend the single best next test and how to arrange it.

Mentioned in position 4 of 8

Short answer: many blood markers predict long-term health and mortality, but the most actionable ones reflect cardiovascular risk, metabolic (glucose/insulin) control, systemic inflammation, kidney/liver function, and basic nutrition/hematologic status. Below are the high-value biomarkers, why they matter, what direction is desirable, and practical testing options. High-value biomarkers (what they measure and why they matter) ApoB / non‑HDL cholesterol (and LDL-C) Why: ApoB (or non‑HDL) better captures atherosclerotic particle burden than HDL alone; strongly linked to cardiovascular events and longevity. Direction: lower is better; targets depend on risk (discuss with clinician). Lp(a) (lipoprotein(a)) Why: genetically determined CVD risk factor not changed by lifestyle; high levels increase early CVD risk. Direction: identify high levels to guide more aggressive risk reduction. HbA1c and fasting glucose (plus fasting insulin or HOMA-IR) Why: glycemic control predicts diabetes and vascular complications; insulin resistance predicts metabolic aging. Direction: aim for normal glycemia; even high‑normal values predict higher long‑term risk. High-sensitivity CRP (hs‑CRP) and other inflammatory markers (IL‑6, GlycA) Why: chronic low-grade inflammation strongly predicts cardiovascular disease, frailty, and mortality. Direction: lower is better. IL‑6 and GlycA are more specialized but informative. High-sensitivity cardiac troponin and NT‑proBNP Why: sensitive markers of subclinical cardiac injury and cardiac strain; predict heart failure and mortality even in asymptomatic people. Direction: lower is better. eGFR (creatinine) and cystatin C Why: kidney function predicts all‑cause mortality; cystatin C can detect earlier decline. Direction: higher eGFR / lower cystatin C within normal ranges is better. Albumin (serum albumin) Why: low albumin signals malnutrition, inflammation, frailty; predicts mortality, especially in older adults. Direction: higher (within normal) is better. Complete blood count parameters: hemoglobin, RDW, white blood cell count Why: anemia, high RDW, and elevated WBC associate with poorer outcomes and mortality. Direction: within normal, avoid anemia/elevated RDW/WBC. Liver enzymes (GGT, ALT, AST) Why: GGT and other enzymes correlate with metabolic health, alcohol use, fatty liver — all linked to long‑term risk. Direction: lower/normal. Vitamin D (25‑OH D), B12, ferritin Why: deficiencies relate to frailty, falls, cognitive decline, and worse outcomes. Direction: replete to optimal ranges recommended by clinicians. Thyroid function (TSH ± free T4) Why: thyroid disorders affect metabolism, cardiovascular risk, cognition, and longevity. Direction: euthyroid state is best. IGF‑1 (and growth factor signaling) Why: IGF‑1 is implicated in aging biology; relationships are complex (both low and high levels have risks). Useful in research/clinical contexts but interpret cautiously. Direction: mid‑range may be preferable; discuss with a specialist. ApoA1, omega‑3 index Why: ApoA1/HDL functionality and omega‑3 status associate with cardiovascular mortality risk. Direction: higher omega‑3 index associated with lower risk. Homocysteine Why: elevated homocysteine links to vascular and cognitive risk; often modifiable with B vitamins if elevated. Advanced/optional tests (use if higher risk, family history, or for research/optimization) NMR lipoprofile (LDL particle number — LDL‑P) GlycA (NMR inflammation marker) Specialized cytokines (IL‑6, TNF‑α) Genetic tests (APOE genotype relevant to Alzheimer risk; LPA gene for Lp(a) insights) Telomere length and epigenetic clocks — interesting for research but not yet routine clinical guidance Practical testing — where to get them (brands/services) Clinical labs (for physician-ordered tests): Quest Diagnostics, LabCorp, Mayo Clinic Laboratories — comprehensive, reliable, widely used by doctors. Direct-to-consumer / consumer-friendly platforms (some tests available without a clinician visit; discuss abnormal results with your provider): InsideTracker — broad, action-oriented panels plus lifestyle recommendations. Everlywell and LetsGetChecked — home collection kits for common labs (lipids, HbA1c, thyroid, vitamin D). OmegaQuant — specialized omega‑3 index testing. Cleveland HeartLab — specialized cardiovascular inflammation and advanced lipid testing. SpectraCell — micronutrient testing (if you suspect nutrient deficiencies). Note: ApoB, Lp(a), NMR lipoprofile and high-sensitivity cardiac markers are available through major clinical labs (Quest/LabCorp) and some specialty services. How to use this information Prioritize based on age and risk: Under ~40 and low risk: basic lipid panel, fasting glucose or HbA1c, CBC, CMP, vitamin D as needed. Over ~40 or with family history: add ApoB (or non‑HDL), Lp(a) once, hs‑CRP, eGFR/cystatin C, hs‑troponin/NT‑proBNP if cardiac risk. Known metabolic/CVD disease: more frequent, include advanced lipid testing and inflammatory markers. Frequency: annually for stable adults; every 3–6 months if changing therapy, abnormal results, or higher risk. Actionability matters: use labs that will change management (lifestyle or meds). For example, high ApoB or LDL → statin discussion; high HbA1c → lifestyle + medical therapy; elevated hs‑CRP/IL‑6 → focus on anti‑inflammatory lifestyle changes and treat risk factors. Bottom line Focus first on cardiovascular risk (ApoB/non‑HDL, LDL, Lp(a)), glycemic control (HbA1c/glucose/insulin resistance), and chronic inflammation (hs‑CRP, IL‑6). Complement that with kidney/liver function, basic nutrition/hematologic labs, vitamin D/B12, and targeted cardiac markers (NT‑proBNP, hs‑troponin) when indicated. Use trusted clinical labs (Quest, LabCorp, Mayo) for diagnostic accuracy and consider consumer services (InsideTracker, OmegaQuant, Cleveland HeartLab) for additional or convenience testing. Always review abnormal results with your clinician to plan interventions tailored to your overall risk. If you want, tell me your age, sex, family history and any known conditions and I’ll suggest a prioritized list of tests and how often to check them.

Mentioned in position 3 of 9

Short answer — several routine blood biomarkers are strongly associated with long-term health and mortality risk. They cluster around metabolic health (glucose/insulin), lipid/atherosclerosis risk, inflammation, kidney/liver function, hematologic status, micronutrients, and a few specialty markers and "biological age" tests. Below I list the most useful markers, why they matter, typical direction you want them to go, which test measures them, and a few services/companies that can run or interpret them. Important disclaimer: this is general information, not medical advice. Discuss abnormal results and treatment decisions with your clinician. Top-priority biomarkers for longevity (what to test and why) Hemoglobin A1c (A1c), fasting glucose, fasting insulin (or HOMA-IR) Why: chronic higher glucose and insulin resistance drive diabetes, vascular disease, dementia. Direction: lower within normal — A1c <5.7% is ideal; fasting glucose <100 mg/dL; lower fasting insulin and HOMA-IR indicate better metabolic health. How to test: standard lab panels. Lipids: LDL-C, non‑HDL, triglycerides, HDL — and better predictors: ApoB and ApoA1 Why: lipid-related atherosclerotic risk is the main driver of premature cardiovascular death. Direction: lower LDL-C/ApoB/non‑HDL; higher HDL (within reason); low triglycerides. ApoB is often a better single-number predictor than LDL-C. How to test: standard lipid panel + ApoB. Lp(a) (lipoprotein(a)) Why: genetically driven risk factor for atherosclerosis; important to know once. Direction: lower is better; elevated Lp(a) increases lifetime CV risk. How to test: single blood test. High-sensitivity CRP (hs‑CRP), and if available IL‑6 or fibrinogen Why: markers of chronic systemic inflammation predict cardiovascular events and mortality. Direction: hs‑CRP <1 mg/L is low-risk; higher indicates increased risk. Kidney function: serum creatinine, eGFR, and cystatin C when available Why: kidney disease strongly increases mortality risk. Direction: higher eGFR / lower creatinine (age-adjusted); cystatin C can detect impairment earlier. Liver enzymes: ALT, AST, GGT Why: fatty liver and liver dysfunction are linked to metabolic disease and mortality. Direction: lower or within normal range; elevated GGT often signals metabolic stress or alcohol use. Complete blood count (CBC) including red cell distribution width (RDW), hemoglobin, hematocrit Why: anemia and elevated RDW correlate with mortality and frailty. Direction: avoid anemia; lower RDW is better. Serum albumin and prealbumin Why: markers of nutrition / physiologic reserve; low albumin predicts worse outcomes. Direction: higher within normal range. Ferritin and iron studies (if iron disorder suspected) Why: both iron deficiency and iron overload have health consequences. Direction: context-dependent — treat deficiency; avoid excess. Vitamin D (25‑OH vitamin D) Why: low vitamin D associates with higher mortality and multiple chronic diseases. Direction: many experts aim for 30–50 ng/mL (discuss with clinician). Homocysteine Why: associated with vascular risk and cognitive decline in some studies. Direction: lower is better; treatable with B vitamins if elevated. Specialty or advanced markers / biological aging tests ApoB/ApoA1 ratio and advanced lipoprotein testing (NMR) Why: refines cardiovascular risk beyond standard lipids. Services: Quest, LabCorp, and specialized labs. Lipoprotein(a) — see above (genetic risk) Cystatin C (more sensitive kidney marker) High-sensitivity troponin (in some research settings) for silent cardiac risk D‑dimer, NT‑proBNP in selected cases (cardiac/clotting risk) Telomere length, epigenetic clocks (DNAm GrimAge, DNAm PhenoAge) Why: attempt to estimate biological age rather than chronological age. Research-useful but clinical utility is still emerging. Providers: TruDiagnostic (epigenetic clock tests), Zymo Research / Chronomics (some services), EpiAging technologies. Expect higher cost and evolving interpretation. Practical prioritization if you want to test only a few things Essentials: A1c (or fasting glucose), fasting lipid panel + ApoB, hs‑CRP, CBC, basic metabolic panel (creatinine/eGFR), ALT/AST, and vitamin D. If you have family history of early heart disease: add Lp(a) and advanced lipid testing. If concerned about biological age or prevention investment: consider epigenetic clock testing via TruDiagnostic or similar. Where to get these tests and interpretation (brands/services) Local clinical labs: Quest Diagnostics and LabCorp — widely available, accepted by clinicians and insurers. Direct-to-consumer / at-home kits: Everlywell, LetsGetChecked — convenient for many standard tests (A1c, lipids, vitamin D, thyroid). Interpretation + coaching platforms: InsideTracker, WellnessFX, and Thorne’s personalized lab services — they provide interpretation, personalized recommendations, and repeat testing plans. Continuous glucose monitoring and metabolic coaching: Abbott FreeStyle Libre or Dexcom + Levels app (Levels provides CGM-based coaching) — useful for understanding glucose spikes in non-diabetics. Epigenetic/biological-age testing: TruDiagnostic — focused on DNAm clocks and provides longitudinal reports; other players include Chronomics and Zymo Research (myDNAge). Specialty / research labs: Mayo Clinic Laboratories for complex panels; Quest/LabCorp also offer advanced tests (ApoB, Lp(a), NMR lipoprofile). How often to test Baseline and then annually for most markers if normal. Every 3–6 months if you’re making an intervention (starting statin, weight loss, diabetes therapy) or if values are abnormal. What actually improves longevity (brief) Lowering long-term exposure to high glucose/insulin, lowering atherogenic lipoproteins (ApoB/LDL), reducing chronic inflammation, preserving kidney and liver function, avoiding anemia and severe micronutrient deficiencies, and maintaining muscle mass and physical fitness. Proven interventions include lifestyle (diet quality, regular physical activity, adequate sleep, smoking cessation), control of blood pressure and lipids (including statins when indicated), and glycemic control in people with diabetes. Work with your clinician for medication decisions. If you want, I can: Suggest a compact “starter panel” tailored to your age/sex/family history. Point to which companies or test kits would be best for a specific marker (e.g., where to get ApoB, Lp(a), epigenetic clock). Explain target ranges in more detail for any one marker. Which would you like next?

Mentioned in position 14 of 14